­

About admin

This author has not yet filled in any details.
So far admin has created 77 blog entries.

OncBioMune Reports Record Monthly Sales for Bekunis(R) in May

BATON ROUGE, LA--(May 31, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company [...]

OncBioMune Receives Approval for Male Fertility Product in Mexico

BATON ROUGE, LA--(May 30, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company [...]

OncBioMune CMO Begins Formulation Work on Tretinoin for Acute Promyelocytic Leukemia

BATON ROUGE, LA--(May 23, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company [...]

OncBioMune Provides Corporate Update, Nearly 50 Drug Candidates in Pipeline or Being Negotiated

BATON ROUGE, LA--(May 9, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP)("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in [...]

OncBioMune Completes Enrollment in Phase 1 Trial of ProscaVax for Prostate Cancer

BATON ROUGE, LA--(May 03, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company [...]

OncBioMune, AqVida Partner for Commercializing Cancer and Other Generic Drugs in Mexico

Companies Negotiating Joint Venture for Clinical Development of ProscaVax for Prostate Cancer in Europe BATON ROUGE, LA--(April 26, 2017) - [...]

OncBioMune Licenses Tretinoin for the Treatment of Acute Promyelocytic Leukemia Throughout Mexico, Central and Latin America

BATON ROUGE, LA--(April 20, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company [...]

OncBioMune Prepares Submission Seeking Marketing Approval for Anti-D Immunoglobulin in Mexico

BATON ROUGE, LA--(April 18, 2017) - OncBioMune Pharmaceuticals, Inc. (OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged [...]

OncBioMune and Gem Pharmaceuticals Finalizing Partnership Terms to Develop New Cancer Drug for Mexico, Central and Latin America Markets

BATON ROUGE, LA--(March 30, 2017) - OncBioMune Pharmaceuticals, Inc. (OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged [...]

OncBioMune Sales of Bekunis® and Cirkused® Exceed Forecast by 164 Percent in First Six Months on Market

BATON ROUGE, LA--(March 27, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company [...]